Do We Still Need Bioresorbable Scaffolds in the DES Era? | Prof. (Dr.) Ashok Seth

At EuroPCR 2017 in Paris, I had the opportunity to discuss one of the most important debates in interventional cardiology with Dr. Gregg Stone and Dr. Azeem Latib: the future of bioresorbable scaffold (BRS) technology.
With contemporary drug-eluting stents achieving excellent outcomes through thinner struts and improved designs, an important question remains: does bioresorbable technology still have a role in coronary intervention?
In this discussion, we explore the evolving evidence, long-term benefits, patient selection, dual antiplatelet therapy strategies, and the future direction of scaffold-based therapies in coronary artery disease.

#DrAshokSeth #EuroPCR2017 #BioresorbableScaffold #InterventionalCardiology #CoronaryArteryDisease #PCI

Dr Ashok Seth, EuroPCR 2017, bioresorbable scaffold, BRS technology, drug eluting stent, dual antiplatelet therapy, interventional cardiology

For Appointment or Consultation : -
Fortis Escorts Heart Institute & Research Centre, Okhla Road, New Delhi - 110025 (INDIA)
Ph : - 011 - 47135000, 011 - 26825013
=================================================================
Stay Connected:
Twitter - twitter.com/Dr_AshokSeth
Linkedin - linkedin.com/in/drashokseth
Facebook - facebook.com/DrAshokSeth.HM
Instagram - instagram.com/dr_ashokseth

#HeartHealth #CardiologistTips #HeartAttackPrevention #HealthyHeart